Covishield: News

17 May 2024


After Covishield, new study finds side effects in Covaxin recipients

A recent study published in Springer Nature revealed that over 30% of Covaxin recipients reported "adverse events of special interest" (AESI).

02 May 2024


Should I be worried if I have taken AstraZeneca's Covishield?

AstraZeneca, the pharmaceutical company behind the Covishield COVID-19 vaccine, recently acknowledged the potential risk of Thrombosis with Thrombocytopenia Syndrome (TTS) as a side effect.

01 May 2024


Astrazeneca upholds vaccine safety amid health concerns

AstraZeneca has reaffirmed its dedication to patient safety amid reports of rare side effects from the AstraZeneca-Oxford COVID-19 vaccine.

30 Apr 2024


Explained: What's TTS, rare condition caused by AstraZeneca's Covishield vaccine 

In a significant development, AstraZeneca, the manufacturer of the Covishield vaccine, has acknowledged in legal documents that its vaccine may trigger a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS).

Covishield manufacturer SII duped of Rs. 1 crore, 7 arrested

In a major cheating and cyber fraud case, the Serum Institute of India (SII) has been duped of Rs. 1 crore.

03 Sep 2022

Bombay High Court

Covishield death: Bombay HC notice to Centre, Serum Institute, DCGI

A man has filed a compensation suit against the Indian vaccine maker Serum Institute of India (SII) for Rs. 1,000 crore, claiming that the side effects of the Covishield vaccine killed his daughter last year.

COVAXIN, Covishield will now be available in hospitals and clinics

The Drugs Controller General of India (DCGI) on Thursday granted approval for regular market sale to India's two most prevalent COVID-19 vaccines—COVAXIN and Covishield.

02 Dec 2021

Union Health Ministry

COVID-19: India reports 9K+ infections; 477 more deaths

India on Thursday reported over 9,000 new COVID-19 cases with an active caseload of just under one lakh.

08 Oct 2021


No quarantine for fully vaccinated Indians in UK from Monday

The United Kingdom has announced that Indians who are fully vaccinated with Covishield or any other UK-approved coronavirus vaccine will not have to quarantine upon arrival in Britain from Monday, October 11.

25 Sep 2021


Date of birth on Co-WIN certificates for passengers traveling abroad

People who are fully inoculated and want to travel abroad will have a Co-WIN certificate with their full date of birth, official sources said on Saturday amid ongoing discussions between India and the UK over COVID-19 vaccination certificates.

22 Sep 2021

S Jaishankar

UK recognizes Covishield, but Indians still need to quarantine

The United Kingdom on Wednesday revised its travel advisory, listing Covishield as an approved COVID-19 vaccine.

21 Sep 2021


UK's decision to not recognize Covishield discriminatory, says India

India on Tuesday issued a sharp reaction to the United Kingdom's decision to not recognize Covishield as a legitimate COVID-19 vaccine.

21 Sep 2021

S Jaishankar

India criticizes new UK travel rules; Jaishankar raises issue

India's External Affairs Minister S Jaishankar has pushed for a resolution of the COVID-19 quarantine issue faced by Indians in the United Kingdom.

20 Sep 2021

Shashi Tharoor

Smacks of racism: Ramesh, Tharoor slam UK's COVID-19 travel rules

Former Union ministers Jairam Ramesh and Shashi Tharoor on Monday slammed the UK's COVID-19-related travel rules under which Indians vaccinated with Covishield would still be treated as unvaccinated.

24 Aug 2021


Kerala HC questions Centre about 84-day gap between Covishield doses

The Kerala High Court on Tuesday asked the Centre whether the 84-day gap between two doses of Covishield was based on the availability of the vaccine or its efficacy.

SII's Poonawalla bats for booster dose, opposes mixing of vaccines

Serum Institute of India Chairman Cyrus Poonawalla on Friday said that taking a third or booster dose of Covishield, the coronavirus vaccine manufactured by his firm was desirable.

India's drug regulator approves study on mixing Covishield, COVAXIN jabs

The Drugs Controller General of India (DCGI) has approved a proposal to conduct a study on the mixing of Covishield and COVAXIN COVID-19 vaccines.

08 Aug 2021


Mixing of Covishield, COVAXIN vaccines gives positive results: ICMR study

A study conducted by the Indian Council of Medical Research (ICMR) has indicated that mixing and matching of COVID-19 vaccines Covishield and COVAXIN can yield better results.

04 Aug 2021


Amid third wave fears, Covishield proven highly effective against Delta

The Delta variant is highly-transmissible and possibly leads to a more severe disease of COVID-19.

04 Aug 2021


India mulls mixing Covishield, Sputnik doses; no recommendation yet

India is considering allowing the mixing of different COVID-19 vaccine doses in what could be the first mix-and-match inoculation.

28 Jul 2021


As vaccination pace remains slow, Centre may reduce private quota

The Centre may soon reduce the 25% quota of COVID-19 vaccine supply for private facilities for their failure to pick up the earmarked quota.

17 Jul 2021


Government to procure 66 crore doses of Covishield, COVAXIN

The Centre has placed an order to procure 66 crore doses of Covishield and COVAXIN to be supplied between August and December this year, at a revised price of Rs. 205 and Rs. 215 per dose, respectively, excluding taxes, official sources said.

17 Jul 2021


EU body says it didn't receive application for Covishield approval

The European Medicines Agency (EMA) said it has not received any application for the authorization of the coronavirus vaccine Covishield.

Seven EU nations, Switzerland approve India-made Covishield for 'Green Pass'

The European Union's (EU) Digital COVID Certificate framework to allow easier, restriction-free movement of vaccinated travelers within European countries—excluding India-made Covishield and COVAXIN vaccines—comes into force on Thursday.

'Not received Covishield approval request,' says EU body amid concerns

The Serum Institute of India (SII) has not yet applied for the approval of its coronavirus vaccine Covishield in the "Green Pass" issued by the European Union, according to a statement from the EU.

28 Jun 2021


India takes up Covishield's exclusion from the EU's 'Green Pass'

Covishield, the Indian version of the Oxford-AstraZeneca vaccine, has been excluded from the European Union's "Green Pass."

10 Jun 2021

COVID-19 Vaccine

AstraZeneca vaccine linked to small risk of low blood platelets

The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a small risk of developing a blood condition characterized by low platelet counts, according to a UK study.

10 Jun 2021


After updating vaccine policy, Centre may renegotiate Covishield, COVAXIN prices

After India's COVID-19 vaccination policy was updated this week, the central government is likely to renegotiate prices for vaccines, a report suggested.

09 Jun 2021


Second Covishield dose in 28 days for some in Punjab

The second dose of the Covishield vaccine will now be administered after 28 days to people who have to travel abroad for specific purposes, Punjab Health Minister Balbir Singh Sidhu said on Tuesday.

27 May 2021

Uttar Pradesh

1st dose Covishield, 2nd dose COVAXIN: Vaccination blunder in UP

In a grave oversight, a group of villagers in Uttar Pradesh received two shots of two different vaccines: COVAXIN and Covishield (both two-dose vaccines).

19 May 2021


Karnataka targets vaccinating eligible population by 2021 end

The Karnataka government has set a goal to vaccinate all eligible people in the state by November end against coronavirus.

16 May 2021


COVAXIN, Covishield effective, but produce fewer antibodies against B.1.617: Report

According to a series of early reports authored by scientists at the Indian Council of Medical Research (ICMR), COVAXIN and Covishield—vaccines deemed effective at generating an immune response against COVID-19—appear to generate only half as many antibodies against the B.1.617 variant.

13 May 2021


Government panel recommends 12-16 week gap between Covishield doses

A government expert panel has reportedly recommended raising the time gap between two doses of the COVID-19 vaccine Covishield to 12-16 weeks.

04 May 2021


Give priority to Maharashtra in vaccine allocation: Tope to Poonawalla

Maharashtra Health Minister Rajesh Tope on Monday urged Serum Institute of India Chief Executive Officer Adar Poonawalla to give priority to the state in providing its anti-coronavirus vaccine, Covishield, as the government was ready to purchase doses from the Pune-based company.

28 Apr 2021


Covishield price reduced to Rs. 300 for states: Adar Poonawalla

Adar Poonawalla, the CEO of the Serum Institute of India (SII), on Wednesday announced that the price of the COVID-19 vaccine Covishield was being reduced from Rs. 400 to Rs. 300 for states.

27 Apr 2021


Maharashtra may get Covishield supply only after May 20

Maharashtra Health Minister Rajesh Tope today said that the state may receive its supply of the Covishield vaccine only after May 20.

26 Apr 2021


Coronavirus: United States will send raw material required for Covishield

Just as India is fighting a devastating second wave of coronavirus, the Joe Biden administration in the United States has pledged to help the Asian nation.

21 Apr 2021


Coronavirus: 0.04% people infected after COVAXIN shot; 0.03% after Covishield

The central government on Wednesday said that a "very small" fraction of people have tested positive for COVID-19 after being vaccinated.

21 Apr 2021


SII fixes Covishield's price at Rs. 600 for private hospitals

Serum Institute of India (SII) will sell Covishield at Rs. 400 per shot to states and at Rs. 600 to private hospitals, the Pune-based vaccine manufacturer said today.

06 Apr 2021


Covishield 90% effective if doses given 2-3 months apart: Poonawalla

The efficacy of the COVID-19 vaccine Covishield could increase to 90% if the two doses are given 2.5-3 months apart, Serum Institute of India CEO Adar Poonawalla said Monday.

05 Apr 2021

Coronavirus Vaccine

118-year-old woman possibly oldest in India to get COVID-19 vaccine

A woman, whose age according to her Aadhaar Card is 118 years, has received her first dose of the COVID-19 vaccine in the Sagar district of Madhya Pradesh.

23 Mar 2021


COVAXIN, Covishield not linked to increased risk of blood clotting

There is no heightened risk of blood clotting after vaccinations with indigenous COVAXIN and Covishield, the coronavirus vaccine developed by AstraZeneca and the University of Oxford, a top government committee concluded, reports Indian Express.

22 Mar 2021


Covishield dose gap to be increased to 6-8 weeks: Centre

The time gap between two doses of the Covishield vaccine should be increased to six-to-eight weeks for improved results, the central government has written to all states and Union Territories.

21 Mar 2021


SII to delay shipments to Brazil, Morocco, and Saudi Arabia

The Serum Institute of India (SII) will reportedly be delaying COVID-19 vaccine supplies to Brazil, Saudi Arabia, and Morocco amid criticism that India is not vaccinating enough people at home.

20 Mar 2021

Randeep Guleria

Protection from COVID-19 vaccine possibly lasts 8-10 months: AIIMS Director

The COVID-19 vaccine should be able to give good protection from the infection for eight to ten months or even more, AIIMS Director Dr. Randeep Guleria said on Saturday.

10 Mar 2021

West Bengal

Elderly man dies after shot of COVID-19 vaccine in Bengal

A senior citizen in Dhupguri city in Jalpaiguri District of West Bengal died allegedly after being administered the Covishield vaccine, prompting his family members to lodge a police complaint, an official said on Tuesday.

27 Feb 2021


COVID-19 vaccination: Private hospitals can't charge more than Rs. 250/shot

Private hospitals and healthcare facilities participating in the second phase of the country's COVID-19 vaccination drive will be allowed to charge up to Rs. 250 per shot from the beneficiaries, said the Health Ministry on Saturday.

27 Feb 2021


Private hospitals to charge for COVID-19 vaccine: Details here

As India prepares to inoculate people above 60 years and those over 45 years with comorbidities against COVID-19 from March 1, the Centre on Friday said private hospitals would charge up to Rs. 100 for vaccine administration.

26 Feb 2021

Narendra Modi

WHO lauds India for helping over 60 nations with vaccines

The Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus has lauded Prime Minister Narendra Modi's commitment to supporting vaccine equity and sharing COVID-19 vaccines with over 60 countries across the world, hoping that the other nations will follow his example.

25 Feb 2021


Are you eligible for COVID-19 vaccination? Should you get it?

India is scheduled to begin the second phase of its COVID-19 vaccination drive from March 1.

COVID-19 vaccines: SII to play huge role in mass production

British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.

23 Feb 2021

Coronavirus Vaccine

Sanitation worker dies from health complications; son blames COVID-19 vaccine

A 54-year-old sanitation worker died from health complications, days after he was administered a coronavirus vaccine, according to his son.

19 Feb 2021


Madras HC notice to Centre in case over Covishield side-effects

The Madras High Court on Friday issued a notice to the central government, among others, in a case pertaining to the alleged adverse reaction to the COVID-19 vaccine Covishield.

19 Feb 2021

Sri Lanka

Sri Lanka to purchase ten million Covishield doses from India

Sri Lanka will purchase ten million doses of Oxford-AstraZeneca's Covishield vaccine from India, officials have said.

06 Feb 2021

S Jaishankar

Twenty-five countries in queue for Made in India COVID-19 vaccine

India has so far supplied the COVID-19 vaccine to 15 countries and another 25 nations are in the queue at different levels for the jab, External Affairs Minister S Jaishankar said on Saturday.